Evidence map›Paper›PMID 25176006›Full record

ArticleVeterinary immunology and immunopathology2014

Epitope shifting of gp90-specific cellular immune responses in EIAV-infected ponies.

Chong Liu, Sheila J Cook, Jodi K Craigo, Frank R Cook, Charles J Issel, Ronald C Montelaro, David W Horohov

Abstract read
In one paragraph

Article in Veterinary immunology and immunopathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Chong LiuDepartment of Veterinary Science, University of Kentucky, Lexington, KY, USA.
Sheila J CookDepartment of Veterinary Science, University of Kentucky, Lexington, KY, USA.
Jodi K CraigoCenter for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
Frank R CookDepartment of Veterinary Science, University of Kentucky, Lexington, KY, USA.
Charles J IsselDepartment of Veterinary Science, University of Kentucky, Lexington, KY, USA.
Ronald C MontelaroCenter for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, PA, USA.
David W HorohovDepartment of Veterinary Science, University of Kentucky, Lexington, KY, USA. Electronic address: David.Horohov@uky.edu.
University of Kentucky · USUniversity of Pittsburgh · US

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
Kentucky Center for Clinical and Translational ScienceUL1TR000117 · NCATS · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2012 to 2015
$13.3M
IMMUNOLOGIC MANAGEMENT OF LENTIVIRUS INFECTIONS--EIAVR01AI025850 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MONTELARO, RONALD C · 1987 to 2013
$7.1M
KENTUCKY CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCEUL1RR033173 · NCRR · UNIVERSITY OF KENTUCKY · PI KERN, PHILIP A · 2011 to 2011
$3.5M
NCATS NIH HHS UL1 TR000005NCATS NIH HHS UL1 TR000117NCRR NIH HHS UL1 RR033173NCRR NIH HHS UL1RR033173NIAID NIH HHS R01 AI025850NIAID NIH HHS R01 AI25850-23
6 · The paper itself

Abstract

Unlike other lentiviruses, EIAV replication can be controlled in most infected horses leading to an inapparent carrier state free of overt clinical signs which lasts for many years. While the resolution of the initial infection is correlated with the appearance of virus specific cellular immune responses, the precise immune mechanisms responsible for control of the infection are not yet identified. Since the virus undergoes rapid mutation following infection, the immune response must also adapt to meet this challenge. We hypothesize that this adaptation involves peptide-specific recognition shifting from immunodominant variable determinants to conserved immunorecessive determinants following EIAV infection. Forty-four peptides, spanning the entire surface unit protein (gp90) of EIAV, were used to monitor peptide-specific T cell responses in vivo over a six-month period following infection. Peptides were injected intradermally and punch biopsies were collected for real-time PCR analysis to monitor the cellular peptide-specific immune responses in vivo. Similar to the CMI response to HIV infection, peptide-specific T cell recognition patterns changed over time. Early post infection (1 month), immune responses were directed to the peptides in the carboxyl-terminus variable region. By six months post infection, the peptide recognition spanned the entire gp90 sequence. These results indicate that peptide recognition broadens during EIAV infection.

Indexed as

EpitopesAmino Acid SequenceAnimalsAntibodies, ViralAntibody AffinityEquine Infectious AnemiaGene Expression Regulation, ViralGenetic VariationGlycoproteinsHorsesImmunity, CellularInfectious Anemia Virus, EquineViral ProteinsAntibodies, ViralEpitopesGlycoproteinsViral ProteinsCellular immune responsesEIAVEnvelopeImmunodominant shiftingLentivirus

Identifiers

PMID25176006
PMCPMC4337894
OpenAlexW2009842102

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.